Haemophilia

Congratulations to

Susanna Lövdahl

for being the first recipient of theChristine Lee Haemophilia Journal Award, chosen by the selection committeein recognition of the best article published in Haemophilia in a calendar year.

Susanna will receive $3,000 and a three-year personal subscripton to Haemophilia for this outstanding achievement!

WFH Announces New President

The World Federation of Hemophilia is pleased to announce that Alain Weill has been elected president.

WFH 2012 World Congress Webcasts Available

The WFH is pleased to offer webcasts of selected sessions from the WFH 2012 World Congress program. The webcasting service enables you to access full media presentations with animated slides, reproduction of the speaker’s laser pointer movements, and embedded videos. For selected talks, PowerPoint slides are also available for download.

Guidelines for the management of hemophilia

Hemophilia is a rare disorder that is complex to diagnose and to manage. These evidence-based guidelines offer practical recommendations on the diagnosis and general management of hemophilia, as well as the management of complications including musculoskeletal issues, inhibitors, and transfusion-transmitted infections. By compiling these guidelines, the World Federation of Hemophilia aims to assist healthcare providers seeking to initiate and/or maintain hemophilia care programs, encourage practice harmonization around the world and, where recommendations lack adequate evidence, stimulate appropriate studies.

Access the top 10 most downloaded articles in 2011 for FREE, no registration required. Access the top 10 from Haemophilia now!

Read our latest Editor's Choice Articles:

Comment on: Mannucci, P. M. Evolution of the European guidelines for the clinical development of factor VIII products

Haemophilia care in Europe - a survey of 35 countries

Evolution of the European guidelines for the clinical development of factor VIII products: little progress towards improved patient management

Read Professor Christine A. Lee’s choice of 2011 papers, FREE for a limited time:

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011

Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX

A case–control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A

Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations

Haemophilia management: time to get personal?